| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7076dedc2d2a657bb9fccb6f5dbf0296 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 |
| filingDate |
2017-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ba5e08fd5169587f313ceb58ea8338b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15852735df22e7a51710fd8c67c6c01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140232be1e8dbdf5ab889732575d8c28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa924ffef4332596e6b012fca5c569fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982261acde02818845f9454d68b34dd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e1669630a071edc3ec8139ed81111bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5346c258015a96fb9457796dd406131f |
| publicationDate |
2018-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2659092-A1 |
| titleOfInvention |
Pharmaceutical composition comprising selective serotonin and galanin reuptake inhibitors (1-15) |
| abstract |
Pharmaceutical composition comprising selective serotonin and galanin reuptake inhibitors (1-15). The present invention relates to the use of galanin (1-15) or a pharmaceutically acceptable salt thereof to be used in combination with a serotonin reuptake inhibitor or any other compound that causes a significant increase in the synthesis of postsynaptic 5HT1A receptors. in terminal areas. In particular, the present invention relates to the use of GAL (1-15) or a pharmaceutically acceptable salt thereof useful for increasing and / or providing a faster onset of the therapeutic effect of a serotonin reuptake inhibitor or any other compound. than a significant increase in the synthesis of postsynaptic 5HT1A receptors in terminal areas. |
| priorityDate |
2017-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |